Biohacker Bryan Johnson and His Blueprint Project
Entrepreneur and biohacker Bryan Johnson invests roughly $2 million annually into his Blueprint initiative, which aims to combat the aging process. He founded the payment startup Braintree in 2007, and six years later, PayPal acquired it for approximately $800 million. Johnson launched the Blueprint project in 2021, with the goal of rejuvenating his body and enhancing his overall health.
Johnson follows a strict daily regimen, going to bed around 8:30 PM and waking at 5:00 AM. His diet consists of 2,250 calories per day, is plant-based, and includes:
- black lentils
- broccoli
- cauliflower
- mushrooms
- garlic
- ginger
- olive oil
- creatine
- collagen
- omega-3
He also engages in physical exercise, performing six hours of strength and cardio training each week. Over 30 doctors and medical professionals monitor his health metrics.
Experiments and Challenges
In 2023, Johnson attempted to reverse aging through plasma exchange, with one of the donors being his 17-year-old son, Talmage. The procedure involved six one-liter plasma exchanges, but the therapy was halted due to a lack of the desired effect. In October 2023, Johnson underwent gene therapy with follistatin, and in March 2024, he received injections of 300 million young mesenchymal stem cells. In November 2025, he announced plans to create an organoid avatar, stating:
“Thousands of miniature Johnsons grown on cell culture dishes, each replicating my cellular and organ biology.”
However, not everything has gone smoothly. In July 2026, Johnson reported being diagnosed with autoimmune gastritis in May of that year. According to medical research, this condition affects 2-5% of the population. At age 21, Johnson was also diagnosed with autoimmune hypothyroidism, and over the past decade, he has struggled with low ferritin levels without anemia. In his own words, Johnson notes:
“In my case, exchanging young plasma does not add any benefit beyond the existing interventions.”
Johnson’s ultimate goal remains unchanged: 'Don't die.' His biohacking experiments and use of cutting-edge medical technologies continue to spark public curiosity and debate, highlighting both the possibilities and the risks tied to modern scientific advances in health and aging.
Johnson’s research and biohacking approaches raise important ethical and safety questions regarding the use of novel medical technologies. His efforts demonstrate how medical innovations can reshape our understanding of aging, while also underscoring the need for thorough examination of potential health risks. This case may serve as a catalyst for further studies in genetic and cellular therapies, opening new frontiers in the fight against aging and chronic diseases.